Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38549
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorMendivil Pérez, Miguel Ángel-
dc.contributor.authorJiménez del Río, Marlene-
dc.contributor.authorVélez Pardo, Carlos Alberto-
dc.date.accessioned2024-03-11T20:18:55Z-
dc.date.available2024-03-11T20:18:55Z-
dc.date.issued2014-
dc.identifier.citationMendivil-Perez, M., Jimenez-Del-Rio, M., & Velez-Pardo, C. (2014). Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: Involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins. Oxidative medicine and cellular longevity, 2014.spa
dc.identifier.issn1942-0900-
dc.identifier.urihttps://hdl.handle.net/10495/38549-
dc.description.abstractABSTRACT: To establish the effect of low (11 mM) and high (55 mM) glucose concentrations (G11, G55) on Jurkat cells exposed to rotenone (ROT, a class 5 mitocan). We demonstrated that ROT induces apoptosis in Jurkat cells cultured in G11 by oxidative stress (OS) mechanism involving the generation of anion superoxide radical (, 68%)/hydrogen peroxide (H2O2, 54%), activation of NF-B (32%), p53 (25%), c-Jun (17%) transcription factors, and caspase-3 (28%), apoptosis-inducing factor (AIF, 36%) nuclei translocation, c-Jun N-terminal kinase (JNK) activation, and loss of mitochondria transmembrane potential (, 62%) leading to nuclei fragmentation (~10% and ~40% stage I-II fragmented nuclei, resp.). ROT induces massive cytoplasmic aggregates of DJ-1 (93%), and upregulation of Parkin compared to untreated cells, but no effect on PINK-1 protein was observed. Cell death marker detection and DJ-1 and Parkin expression were significantly reduced when cells were cultured in G55 plus ROT. Remarkably, metformin sensitized Jurkat cells against ROT in G55. Our results indicate that a high-glucose milieu promotes resistance against ROT/H2O2-induced apoptosis in Jurkat cells. Our data suggest that combined therapy by using mitochondria-targeted damaging compounds and regulation of glucose (e.g., metformin) can efficiently terminate leukemia cells via apoptosis in hyperglycemic conditions.spa
dc.format.extent17 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherHindawispa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleResponse to Rotenone Is Glucose-Sensitive in a Model of Human Acute Lymphoblastic Leukemia: Involvement of Oxidative Stress Mechanism, DJ-1, Parkin, and PINK-1 Proteinsspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Neurociencias de Antioquiaspa
dc.identifier.doi10.1155/2014/457154-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1942-0994-
oaire.citationtitleOxidative Medicine and Cellular Longevityspa
oaire.citationstartpage1spa
oaire.citationendpage17spa
oaire.citationvolume2014spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
oaire.fundernameColombia. Ministerio de Ciencia, Tecnología e Innovaciónspa
dc.publisher.placeNueva York, Esados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsApoptosis-
dc.subject.decsCaspase 3-
dc.subject.decsPeróxido de Hidrógeno-
dc.subject.decsHydrogen Peroxide-
dc.subject.decsForma del Núcleo Celular - efectos de los fármacos-
dc.subject.decsCell Nucleus Shape - drug effects-
dc.subject.decsActivación Enzimática - efectos de los fármacos-
dc.subject.decsEnzyme Activation - drug effects-
dc.subject.decsPéptidos y Proteínas de Señalización Intracelular-
dc.subject.decsIntracellular Signaling Peptides and Proteins-
dc.subject.decsMembrane Potential, Mitochondrial - drug effects-
dc.subject.decsMembrane Potential, Mitochondrial - drug effects-
dc.subject.decsLeucemia-Linfoma Linfoblástico de Células Precursoras-
dc.subject.decsPrecursor Cell Lymphoblastic Leukemia-Lymphoma-
dc.description.researchgroupidCOL0010744spa
oaire.awardnumber1115-545- 31420spa
oaire.awardnumber567-2012.spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D017209-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D053148-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006861-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D053144-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004789-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D047908-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D053078-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D054198-
dc.relation.ispartofjournalabbrevOxid. Med. Cell. Longev.spa
oaire.funderidentifier.rorRoR:03fd5ne08-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
MendivilMiguel_2014_ResponseRotenoneLymphoblastic.pdfArtículo de investigación9.43 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons